When to Contact Your Doctor
Most GLP-1 side effects are uncomfortable but harmless. The nausea, the GI changes, the fatigue — we covered all of that in the previous pages, and the data is clear: the vast majority of side effects are mild, temporary, and resolve on their own as your body adjusts.
But not every symptom should be toughed out. There’s a real difference between “this is annoying” and “this needs medical attention,” and knowing where that line is means you won’t waste time in an ER over normal adjustment symptoms — and you won’t ignore something that actually matters.
That’s what this page is for. We’re going to walk through three tiers: symptoms that are normal and expected, symptoms that deserve a call to your provider, and symptoms that need immediate attention. No scare tactics. Just clear guidelines so you know when to wait, when to call, and when to go.
The Normal Stuff (No Call Needed)
Before we get into the warning signs, let’s be clear about what doesn’t require a call to your doctor. If you’ve read the first two pages in this section, most of this will be familiar — but it’s worth repeating here because anxiety about side effects is real, and people end up calling after-hours lines over things that are a completely normal part of the adjustment.
Expected during dose escalation:
Mild to moderate nausea — comes and goes, responds to smaller meals and hydration, doesn't prevent eating/drinking
Changes in bowel habits — some diarrhea, constipation, or alternating. Gut motility is changing.
Reduced appetite — a feature, not a side effect. Feeling less hungry or full faster is the mechanism at work.
Mild headaches — common in first weeks, often linked to eating/hydration changes. Drink more water.
Fatigue — body adjusting to different energy intake. Normal if mild and doesn't interfere with daily life.
Mild bloating or gas — digestive system adapting to slower motility.
Slight injection site redness — small pink area that fades in a day or two. About 1–3% of people.[1][2]
None of these require a call to your provider. They might be worth mentioning at your next scheduled appointment, but they’re part of the adjustment process that the vast majority of people move through without issue.
When to Call Your Provider (Soon, Not Emergently)
These are symptoms that need medical input but aren’t emergencies. They typically mean something about your treatment plan may need adjusting — a dose change, a temporary pause, or a different management strategy. Call your provider’s office during business hours. If it’s after hours and the symptoms are worsening, most practices have a nurse line — use it.
Nausea or Vomiting That Won’t Quit
Mild nausea is expected. Nausea that persists for more than a few days at the same intensity, or vomiting that happens more than once or twice after a dose increase, is a signal that your current dose may need more time or a different approach.
Call if:
- You’re vomiting more than once or twice per week
- Nausea is lasting more than 3-4 days without improvement after a dose increase
- You can’t maintain adequate fluid intake because of nausea (even if you’re not vomiting)
- You’ve lost the ability to eat enough to function — not just “I’m eating less” (that’s expected), but “I can barely eat anything”
Your provider may extend your time at the current dose, temporarily step back to a lower dose, or add an anti-nausea medication. These are standard tools — not signs of failure.[3]
Dehydration Warning Signs
GLP-1 medications can reduce thirst along with appetite — and if you’re eating less, you’re also getting less water from food. Add vomiting or diarrhea on top, and dehydration can sneak up on you faster than you’d expect.
Call if you notice:
- Dark-colored urine or significantly reduced urine output
- Dizziness or lightheadedness when standing
- Dry mouth and lips that don’t improve with drinking
- Persistent headaches that don’t respond to fluids
This matters beyond comfort. Severe dehydration while on GLP-1 medications has been linked to acute kidney injury in postmarketing reports — primarily in people who were vomiting and not replacing fluids.[4] Your kidneys need adequate hydration to function, and these medications can make it easier to fall behind without realizing it.
Persistent or Worsening Constipation
Some constipation during dose escalation is normal. Constipation that becomes painful, hasn’t improved in 2-3 weeks, or is getting progressively worse rather than better isn’t something to just push through.
Call if:
- You haven’t had a bowel movement in 4+ days
- You’re experiencing significant abdominal discomfort or bloating that interferes with eating
- Over-the-counter remedies (fiber supplements, stool softeners) aren’t helping
Your provider may recommend a different approach to management or evaluate whether something else is contributing.
Heart Rate Changes You Can Feel
GLP-1 medications can increase resting heart rate by a few beats per minute — clinical trials showed an average increase of 1-5 bpm, which most people never notice.[1][5] But if you can feel your heart racing or pounding, that’s different.
Call if:
- You notice a sustained resting heart rate above your normal baseline (not just momentary spikes from caffeine or activity)
- You’re experiencing palpitations — the feeling of your heart pounding or skipping beats
- Heart rate changes are accompanied by dizziness, shortness of breath, or chest tightness
This is almost certainly not dangerous, but it warrants a conversation and possibly an EKG to make sure nothing else is going on.
Mood or Mental Health Changes
Research on GLP-1 medications and mood is still evolving, and the FDA added language about monitoring for suicidal thoughts and behavior to the labels in 2024 — though current large-scale studies haven’t found a clear link.[6] Regardless of what the research eventually concludes, your mental health always matters.
Call if:
- You notice a significant change in mood, increased anxiety, or new feelings of depression after starting the medication or changing doses
- You’re having thoughts of self-harm or suicide — call your provider immediately or the 988 Suicide and Crisis Lifeline (call or text 988)
- You’re experiencing changes in sleep, motivation, or emotional regulation that feel connected to the medication
Your provider can help determine whether what you’re experiencing is medication-related, adjustment-related, or something else entirely.
Red Flags: When to Seek Immediate Care
These are uncommon. In clinical trials, serious adverse events affected a small minority of participants. But uncommon doesn’t mean impossible, and knowing what to watch for means you won’t waste time second-guessing if something genuinely serious shows up.
If you experience any of the following, contact your provider urgently or go to an emergency room.
Signs of Pancreatitis
Pancreatitis — inflammation of the pancreas — is listed as a warning on all GLP-1 medication labels. Large meta-analyses haven’t found a definitive class-wide risk (one analysis showed no statistically significant increase), but individual cases have been reported.[7]
What it feels like:
Persistent, often radiating to the back. Worsens after eating.
Distinctly more severe than typical GLP-1 adjustment symptoms. Tenderness when pressing on upper abdomen.
The key word is severe. This isn’t the mild queasiness of dose escalation. Pancreatitis pain is hard to ignore — people describe it as intense and unrelenting. If you’re experiencing it, don’t try to tough it out.
Signs of Gallbladder Problems
GLP-1 medications are associated with an increased risk of gallbladder disease. A meta-analysis of 76 clinical trials found a roughly 37% higher risk of gallbladder-related events compared to placebo — with higher doses carrying more risk.[8] Rapid weight loss from any cause also increases gallbladder risk, so the medication and the weight loss may both be contributing.
What to watch for:
Especially after eating. May radiate to the right shoulder or back.
Accompanying abdominal pain — especially a combination of these symptoms together.
Gallbladder attacks often come on suddenly and can be extremely painful. They’re treatable, but they need medical evaluation.
Signs of Bowel Obstruction (Ileus)
In 2023, the FDA updated the Ozempic label to include ileus — a condition where the intestines stop moving food along normally. All GLP-1 and tirzepatide labels now carry this warning based on postmarketing reports.[9] It’s rare, but it’s serious.
What to watch for:
Pain that doesn't improve. Complete inability to pass gas or have a bowel movement.
Stomach looks and feels bloated well beyond normal. Vomit may look dark or greenish.
This is fundamentally different from the constipation that’s common during dose escalation. Normal constipation is uncomfortable. Bowel obstruction involves severe pain, significant swelling, and complete inability to pass anything. If you’re wondering “is this normal constipation or something worse?” — the severity of the pain usually makes it clear.
Severe Allergic Reaction
True allergic reactions to GLP-1 medications are very rare, but they can happen.
Seek immediate care if you experience:
Especially with difficulty breathing or swallowing.
Rapid heartbeat combined with swelling or breathing difficulty.
This is standard for any medication — not specific to GLP-1s. Most people will never experience this. But if it happens, it requires immediate treatment.
Thyroid Concerns
GLP-1 medications carry a boxed warning about thyroid C-cell tumors based on animal studies. This hasn’t been confirmed in humans, and the risk — if it exists — appears to be very low. But the warning exists for a reason, and certain symptoms warrant prompt evaluation.[1]
Contact your provider if you notice:
Or difficulty swallowing that's new — actual difficulty getting food down, not the "I feel full" sensation.
Hoarseness that doesn't go away. Shortness of breath not explained by activity level.
These medications are contraindicated in people with a personal or family history of medullary thyroid carcinoma or a condition called MEN 2 (Multiple Endocrine Neoplasia type 2). Your provider should have screened for this before prescribing. If you’re not sure whether this was discussed, bring it up at your next appointment.
Here’s something I’ve learned from years as a paramedic: the difference between “something’s off” and “something’s wrong” is usually pretty clear when it’s happening to you. The mild nausea of dose escalation is annoying. Pancreatitis-level pain is unmistakable. A bit of constipation is uncomfortable. A bowel obstruction is agonizing. Your body is generally pretty good at telling you the difference — the trick is not talking yourself out of what it’s saying. If something feels genuinely wrong, not just uncomfortable, trust that instinct and make the call. I’ve seen too many patients who waited because they didn’t want to “bother” anyone. Your provider would rather get a call that turns out to be nothing than miss something that needed attention.
The Pre-Surgery Conversation
This one deserves its own section because it’s a specific situation with specific stakes.
GLP-1 medications slow down how quickly food empties from your stomach. That’s part of how they work. But it also means that if you need surgery or any procedure involving anesthesia or sedation, your stomach may not be empty when it normally would be — and that creates a risk of pulmonary aspiration (food or liquid getting into your lungs while you’re sedated).[10]
What you need to do:
- Tell your surgeon and anesthesiologist — don't assume they know you're on a GLP-1, even if it's in your chart. Bring it up directly.
- Follow their stop instructions — guidance varies, but many practitioners recommend holding the dose for at least 1–2 weeks before surgery.
- Follow fasting instructions carefully — standard "nothing after midnight" may not be sufficient. Your care team may extend the fasting window.
This applies to any procedure involving general anesthesia or deep sedation — not just major surgery. Endoscopies, colonoscopies, and dental procedures under sedation all count. FDA prescribing labels now include this warning.[10]
If you have any upcoming procedures — including dental work under sedation or routine outpatient procedures — let your prescribing provider know so they can coordinate timing with your GLP-1 medication schedule. This isn’t something to figure out the week before your procedure. Bring it up as soon as the procedure is scheduled.
The "Gray Zone" — Worth Mentioning at Your Next Appointment
Not everything needs a phone call. Some symptoms are worth bringing up at your next scheduled visit — not because they’re alarming, but because they help your provider understand how you’re responding to treatment and whether adjustments might help.
Mention at your next visit if you’re experiencing:
Usually shows up 2–4 months in, related to rate of weight loss (telogen effluvium), not the medication directly. Typically temporary. Gets its own page later.
If you're well past the adjustment period and still dealing with persistent fatigue, check nutritional intake, blood work (thyroid, iron, vitamins), or sleep quality.
Weight loss can change how your body processes blood pressure meds, diabetes drugs, and psychiatric medications. Doses may need adjusting.
Can increase with delayed gastric emptying. May benefit from a short course of antacid medication.
Rapid weight change can temporarily affect joints. Usually improves, but worth tracking.
Even if it doesn't fit a category above. What seems minor to you might be useful information for managing your treatment.
The Bottom Line
The vast majority of GLP-1 side effects are uncomfortable, temporary, and manageable. The serious stuff — pancreatitis, gallbladder disease, bowel obstruction — is uncommon. And the truly dangerous stuff is rare.
But “uncommon” and “rare” aren’t the same as “impossible.” Knowing what to watch for means you can tell the difference between normal adjustment symptoms and something that needs attention. You don’t need to be hypervigilant — just informed.
The simplest rule: if something feels like a different kind of uncomfortable than what you’ve been experiencing — more intense, more sudden, more localized, or just fundamentally different from the mild GI adjustment you’re used to — trust your instinct and reach out to your provider. You’re not being dramatic. You’re not wasting their time. That’s exactly what they’re there for.
The rest of this section covers the practical management strategies — starting with Nausea Management, which is where most people want to go next.
Sources:
- Novo Nordisk. “Wegovy (semaglutide) Prescribing Information.” FDA, 2025.
- Karagiannis, T., et al. “Adverse Events Related to Tirzepatide.” PMC, 2023.
- Trujillo, J.M., et al. “Clinical Recommendations to Manage GI Adverse Events in Patients Treated with GLP-1 RAs.” PMC, 2023.
- National Center for Biotechnology Information (NCBI). “GLP-1 Receptor Agonists and Renal Outcomes.” PMC, 2024.
- Karagiannis, T., et al. “GI adverse events meta-analysis — SURPASS trials.” PMC, 2023.
- U.S. Food and Drug Administration. “FDA Announces Findings from Review of Reports of Suicidal Thoughts or Actions in Patients Taking GLP-1 RAs.” FDA, 2024.
- Cleveland Clinic. “GLP-1 Agonists and Pancreatitis.” ConsultQD, 2024.
- He, L., et al. “Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases.” JAMA Internal Medicine, 2022.
- U.S. Food and Drug Administration. “Ozempic (semaglutide) Prescribing Information.” FDA, 2025.
- Hjerpsted, J.B., et al. “Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.” Journal of Clinical Endocrinology & Metabolism, 2024.
Want to Start Tracking Your Progress?
Printable templates designed for people on GLP-1 medications — side effect trackers, progress logs, meal planners, and more.
View Templates